EVIDENCE FOR A MECHANISM OF DEMYELINATION BY HUMAN JC VIRUS - NEGATIVE TRANSCRIPTIONAL REGULATION OF RNA AND PROTEIN-LEVELS FROM MYELIN BASIC-PROTEIN GENE BY LARGE TUMOR-ANTIGEN IN HUMAN GLIOBLASTOMA CELLS
Lr. Devireddy et al., EVIDENCE FOR A MECHANISM OF DEMYELINATION BY HUMAN JC VIRUS - NEGATIVE TRANSCRIPTIONAL REGULATION OF RNA AND PROTEIN-LEVELS FROM MYELIN BASIC-PROTEIN GENE BY LARGE TUMOR-ANTIGEN IN HUMAN GLIOBLASTOMA CELLS, Journal of medical virology, 49(3), 1996, pp. 205-211
Human JC virus (JCV) is a neurotropic human polyomavirus that was foun
d in the plaques and oligodendroglial cells of the brains of patients
with the fatal demyelinating disease, progressive multifocal leukoence
phalopathy (PML). Transgenic mice expressing JCV large tumor (T)-antig
en from integrated DNA showed dysmyelination in the central nervous sy
stem. However, the role of T-antigen from episomal DNA in the demyelin
ation in PML remains unclear. In this report, we examined the effect o
f episomally expressed JCV T-antigen on the expression of myelin basic
protein (MBP) in U-87 MG human glioblastoma cells to study the mechan
ism of demyelination. Expression assays of the MBP promoter in U-87 MG
detected a 2.5-fold reduction in cells expressing intact T-antigen. N
ext, U-87 MG expressing T-antigen were examined by RNase protection as
says for mRNA accumulation from the endogenous MBP promoter. Also, the
expression of the MBP promoter plasmid was determined using in vitro
transcription assays with extracts from T-antigen expressing cells. Bo
th assays found a similar down-regulation of the MBP promoter by T-ant
igen, confirming that negative regulation occurred at the transcriptio
nal level for the endogenous and exogenous MBP promoters. Furthermore,
in situ immunofluorescence assays and quantitative Western blot analy
sis provided convincing evidence of a similar reduction in the level o
f MBP produced from the functional endogenous gene in U-87 MG glioblas
toma cells expressing T-antigen. Thus, we provide evidence for the rol
e of T-antigen in a transcriptional control mechanism for the demyelin
ation that is caused by JCV in PML patients. (C) 1996 Wiley-Liss, Inc.